YanikGLevineJERatanatharathornV. Tacrolimus (FK506) and methotrexate as prophylaxis for acute graft-versus-host disease in pediatric allogeneic stem cell transplantation. Bone Marrow Transplant2000; 26: 161–167.
4.
TanakaHKurodaAHashimotoM. Physicochemical properties of FK-506, a novel immunosuppressant isolated from Streptomyces tsukubaensis. Transplant Proc1987; 19(5 Suppl 6): 11–16.
ElefanteAMuindiJWestK. Long-term stability of a patient-convenient 1 mg/ml suspension of tacrolimus for accurate maintenance of stable therapeutic levels. Bone Marrow Transplant2006; 37: 781–784.
PrzepiorkaDDevineSFayJ. Practical considerations in the use of tacrolimus for allogeneic marrow transplantation. Bone Marrow Transplant1999; 24: 1053–1056.
10.
SkeensMPaiVGareeA. Twice daily i.v. bolus tacrolimus infusion for GVHD prophylaxis in children undergoing stem cell transplantation. Bone marrow Transplant2012; 47: 1415–1418.
11.
TaorminaDAbdallahHYVenkataramananR. Stability and sorption of FK 506 in 5% dextrose injection and 0.9% sodium chloride injection in glass, polyvinyl chloride, and polyolefin containers. Am J Hosp Pharm1992; 49: 119–122.
12.
UramotoSKitamuraYHiramatsuY. The features regarding the absorption of tacrolimus by PVC and PB tubes and effects of such absorption of tacrolimus on the blood concentration and dosage in patients. Jpn J Pharma Health Care Sci2003; 29: 216–224.